News
March 26, 2025 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial ...
At close: 9 May at 16:00:00 GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback